Caraco gets tentative FDA nod for generic sleep disorder drug

(Reuters) - Provigil tablets had U.S. sales of about $753 million for the 12-month period ended March 31, according to health information provider IMS Data, the company said in a statement.






Read more at Reuters.com Government Filings News